A box of Ozempic made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams/Reuters
The Centers for Medicare & Medicaid Services (CMS) on Monday unveiled a voluntary model designed to expand access to GLP-1 medications for weight management and metabolic health, allowing Medicare Part D plans and state Medicaid agencies to cover these drugs while negotiating lower prices to manage expenses.
The Better Approaches to Lifestyle and Nutrition for Comprehensive Health (BALANCE) Model aims to combine GLP-1 drugs with evidence-based lifestyle interventions to improve long-term outcomes, following recent federal efforts to address affordability barriers to treatments like Ozempic and Wegovy.We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.
Read Full Article: https://www.theepochtimes.com/us/cms-unveils-model-to-expand-coverage-of-certain-weight-loss-drugs-5962449/?utm_source=partner&utm_campaign=whatfinger
